Cite
Coamplification of miR-4728 protects HER2 -amplified breast cancers from targeted therapy
MLA
Maurizio Scaltriti, et al. “Coamplification of MiR-4728 Protects HER2 -Amplified Breast Cancers from Targeted Therapy.” Proceedings of the National Academy of Sciences, vol. 115, Feb. 2018. EBSCOhost, https://doi.org/10.1073/pnas.1717820115.
APA
Maurizio Scaltriti, Jason D. Wells, Bin Hu, Cristina Bernadó Morales, Hisashi Harada, Ming Tan, Joel D. Leverson, Andrew J. Souers, Mikhail G. Dozmorov, Aleix Prat, Laia Paré, Jennifer E. Koblinski, Todd W. Miller, Maninderjit S. Ghotra, Carlotta Costa, Anthony C. Faber, Brad Windle, Konstantinos V. Floros, Mark T. Hughes, … Sosipatros A. Boikos. (2018). Coamplification of miR-4728 protects HER2 -amplified breast cancers from targeted therapy. Proceedings of the National Academy of Sciences, 115. https://doi.org/10.1073/pnas.1717820115
Chicago
Maurizio Scaltriti, Jason D. Wells, Bin Hu, Cristina Bernadó Morales, Hisashi Harada, Ming Tan, Joel D. Leverson, et al. 2018. “Coamplification of MiR-4728 Protects HER2 -Amplified Breast Cancers from Targeted Therapy.” Proceedings of the National Academy of Sciences 115 (February). doi:10.1073/pnas.1717820115.